X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aacr (1) 1
antigens (1) 1
biological markers (1) 1
biomarkers (1) 1
biopsy (1) 1
brain cancer (1) 1
breast cancer (1) 1
cd8 antigen (1) 1
chemical and pharmacologic phenomena (1) 1
chemotherapy (1) 1
cloning (1) 1
disease (1) 1
docetaxel (1) 1
erbb-2 protein (1) 1
foxp3 protein (1) 1
free survival (1) 1
hemic and immune systems (1) 1
her2 (1) 1
immunohistochemistry (1) 1
index medicus (1) 1
lymphocytes (1) 1
medical prognosis (1) 1
metastases (1) 1
metastasis (1) 1
metastatic breast cancer (1) 1
multivariate analysis (1) 1
neoplasms. tumors. oncology. including cancer and carcinogens (1) 1
oncology (1) 1
pd-l1 (1) 1
pd-l1 protein (1) 1
research (1) 1
research article (1) 1
respiratory system (1) 1
skin (1) 1
statistical analysis (1) 1
studies (1) 1
tils (1) 1
trastuzumab (1) 1
trial (1) 1
triple negative (1) 1
tumor-infiltrating lymphocytes (1) 1
tumors (1) 1
working groups (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research, ISSN 1465-5411, 06/2018, Volume 20, Issue 1, pp. 62 - 10
Background: Tumor-infiltrating lymphocytes (TILs) evaluated in primary breast cancer (BC) convey prognostic information. Limited data in the metastatic setting... 
PD-L1 | Metastatic breast cancer | Tumor-infiltrating lymphocytes | HER2 | Triple negative | TRASTUZUMAB | FREE SURVIVAL | DOCETAXEL | CHEMOTHERAPY | TRIAL | RESPIRATORY SYSTEM | DISEASE | TILS | Research | Metastasis | Biological markers
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.